January 2020

  • All
  • --
  • ---
  • -2022
  • 2022-2
  • 2022-2-2-2
  • 2022-deltia-tipoy
  • 2022-deltia-tipoy-2-2
  • 2022-deltia-tipoy-2-2-2-2
  • 2023-deltia-typou
  • 2023-deltia-typou-2-2
  • 2024
  • 257-2
  • 257-2-2-2
  • 266-2
  • Announcements
  • Consolidated Financial Results
  • deltia-tipoy
  • deltia-tipoy-2-2
  • deltia-tipoy-2-2-2-2
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • invitations-2
  • Presentations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Results 2024
  • Share Capital Increase
  • Uncategorized

Peania, January 24th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Mr. Athanasios...

ANNOUNCEMENT Peania, January 24th, 2020 - Lavipharm S.A., as per L.3340/2005 and the 3/347/12.07.2005 resolution of the Hellenic Capital Market Commission, announces that as of January 20th  2020, Mrs. Eleana Nikolopoulou, attorney at law LL.M University of Munich, assumes the responsibility of Head of Legal.   ...

ANNOUNCEMENT Peania, January 16th, 2020 - Lavipharm S.A. announces that the Board of Directors, in its meeting held on January 16th, 2020, accepted Mr. Telemaque Lavidas’ resignation. It was also decided not to replace the resigned board member as per the corporate by-laws stipulated in Article...